» Articles » PMID: 27491665

Protocol for a National Blood Transfusion Data Warehouse from Donor to Recipient

Overview
Journal BMJ Open
Specialty General Medicine
Date 2016 Aug 6
PMID 27491665
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Blood transfusion has health-related, economical and safety implications. In order to optimise the transfusion chain, comprehensive research data are needed. The Dutch Transfusion Data warehouse (DTD) project aims to establish a data warehouse where data from donors and transfusion recipients are linked. This paper describes the design of the data warehouse, challenges and illustrative applications.

Study Design And Methods: Quantitative data on blood donors (eg, age, blood group, antibodies) and products (type of product, processing, storage time) are obtained from the national blood bank. These are linked to data on the transfusion recipients (eg, transfusions administered, patient diagnosis, surgical procedures, laboratory parameters), which are extracted from hospital electronic health records.

Applications: Expected scientific contributions are illustrated for 4 applications: determine risk factors, predict blood use, benchmark blood use and optimise process efficiency. For each application, examples of research questions are given and analyses planned.

Conclusions: The DTD project aims to build a national, continuously updated transfusion data warehouse. These data have a wide range of applications, on the donor/production side, recipient studies on blood usage and benchmarking and donor-recipient studies, which ultimately can contribute to the efficiency and safety of blood transfusion.

Citing Articles

The Swedish Scandinavian donations and transfusions database (SCANDAT3-S) - 50 years of donor and recipient follow-up.

Zhao J, Rostgaard K, Hjalgrim H, Edgren G Transfusion. 2020; 60(12):3019-3027.

PMID: 32827155 PMC: 7754339. DOI: 10.1111/trf.16027.


A Conceptual Framework for Optimizing Blood Matching Strategies: Balancing Patient Complications Against Total Costs Incurred.

van Sambeeck J, de Wit P, Luken J, Veldhuisen B, van den Hurk K, Van Dongen A Front Med (Lausanne). 2018; 5:199.

PMID: 30090809 PMC: 6069448. DOI: 10.3389/fmed.2018.00199.


Why was this transfusion given? Identifying clinical indications for blood transfusion in health care data.

van Hoeven L, Kreuger A, Roes K, Kemper P, Koffijberg H, Kranenburg F Clin Epidemiol. 2018; 10:353-362.

PMID: 29636633 PMC: 5881526. DOI: 10.2147/CLEP.S147142.


Validation of multisource electronic health record data: an application to blood transfusion data.

van Hoeven L, de Bruijne M, Kemper P, Koopman M, Rondeel J, Leyte A BMC Med Inform Decis Mak. 2017; 17(1):107.

PMID: 28709453 PMC: 5512751. DOI: 10.1186/s12911-017-0504-7.

References
1.
Madge H . On Transfusion of Blood. Br Med J. 2010; 1(680):42-4. PMC: 2296741. DOI: 10.1136/bmj.1.680.42. View

2.
Eder A, Dy B, Kennedy J, Notari Iv E, Strupp A, Wissel M . The American Red Cross donor hemovigilance program: complications of blood donation reported in 2006. Transfusion. 2008; 48(9):1809-19. DOI: 10.1111/j.1537-2995.2008.01811.x. View

3.
Biggin K, Warner P, Prescott R, McClelland B . A review of methods used in comprehensive, descriptive studies that relate red blood cell transfusion to clinical data. Transfusion. 2009; 50(3):711-8. DOI: 10.1111/j.1537-2995.2009.02459.x. View

4.
Middelburg R, le Cessie S, Briet E, Vandenbroucke J, van der Bom J . A solution to the problem of studying blood donor-related risk factors when patients have received multiple transfusions. Transfusion. 2010; 50(9):1959-66. DOI: 10.1111/j.1537-2995.2010.02655.x. View

5.
Maki T . Optimizing blood usage through benchmarking. Transfusion. 2007; 47(2 Suppl):145S-148S. DOI: 10.1111/j.1537-2995.2007.01372.x. View